Hyaluronic acid–nimesulide conjugates as anticancer drugs against CD44-overexpressing HT-29 colorectal cancer in vitro and in vivo

Hyaluronic acid–nimesulide conjugates as anticancer drugs against CD44-overexpressing HT-29 colorectal cancer in vitro and in vivo

You-Sin Jian,1 Ching-Wen Chen,1 Chih-An Lin,2 Hsiu-Ping Yu,1 Hua-Yang Lin,3 Ming-Yuan Liao,1 Shu-Huan Wu,1 Yan-Fu Lin,1 Ping-Shan Lai1,2,4,5 1Department of Chemistry, 2PhD Program in Tissue Engineering and Regenerative Medicine, National Chung Hsing University, Taichung, 3Preclinical Development Re...

Full description

Bibliographic Details
Main Authors: Jian YS, Chen CW, Lin CA, Yu HP, Lin HY, Liao MY, Wu SH, Lin YF, Lai PS
Format: Article
Language:English
Published: Dove Medical Press 2017-03-01
Series:International Journal of Nanomedicine
Subjects:
COX-2 inhibitor
nimesulide
Hyaluronic Acid
CD44
Colorectal cancer
Online Access:https://www.dovepress.com/hyaluronic-acidndashnimesulide-conjugates-as-anticancer-drugs-against--peer-reviewed-article-IJN

Internet

https://www.dovepress.com/hyaluronic-acidndashnimesulide-conjugates-as-anticancer-drugs-against--peer-reviewed-article-IJN

Similar Items